Athenex announces appointment of chief financial officer

Buffalo, n.y., feb. 22, 2022 (globe newswire) -- athenex, inc., (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that mr. joe annoni will join athenex as its new chief financial officer and officer of the company, effective immediately.
ATNX Ratings Summary
ATNX Quant Ranking